Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers

Clinical trial NCT05965414 · COMPLETED

Trial details

NCT number: NCT05965414
Sponsor: Artery Therapeutics, Inc.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2023-10-23
Primary completion: 2024-07-31
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.